Population-based studies of AD: Message and methods: An epidemiologic view

Statistics in Medicine

Volumn 23, Issue 2, 2004, Pages 191-197

  Launer, L J ^a  

^a Epidemiol   (United States)

Author keywords

Cohor study; Dementia; Epidemiology; Methods

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DISEASE COURSE; EXPERIMENTAL DESIGN; EXPOSURE; GENETIC SUSCEPTIBILITY; HUMAN; LONGITUDINAL STUDY; ONSET AGE; OUTCOMES RESEARCH; POPULATION RESEARCH; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

ALZHEIMER DISEASE; COHORT STUDIES; DEMENTIA; HUMANS; POPULATION SURVEILLANCE; RISK FACTORS; UNITED STATES;

EID: 0345832271     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1708     Document Type: Article

References (35)

1. Launer LJ, Hofman A. Frequency and impact of neurologic diseases in the elderly of Europe: a collaborative study of population-based cohorts. Neurology 2000; 54(Suppl 5):S1-S3.
2. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MMB, Copeland JRM, Dartigues J-F, Jagger C, Martinez-Lage J, Soininen H, Hofman A. For the Neurologic Diseases in the Elderly Research Group. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54(Suppl 5):S4-S9.
3. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999; 52:78-84.
4. Launer U. Overview of incidence studies conducted in Europe. Neuroepidemiology 1992; 11(Suppl 1):2-13.
5. White L, Petrovitch H, Ross W, Masaki KH, Abbott RD, Teng EL, Rodriguez BL, Blanchette PL, Havlik RJ, Wergowske G, Chiu D, Foley DJ, Murdaugh C, Curb JD. Prevalence of dementia in older Japanese-American men in Hawaii-The Honolulu-Asia aging study. Journal of American Medical Association 1996; 276: 955-960.
6. Merchant C, Tang MX, Albert S, Manly J, Stern Y, Mayeux R. The influence of smoking on the risk of Alzheimer's disease. Neurology 1999; 52:1408-1412.
7. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, van Duijn CN, van Broeckhoven C, Grobbee DE. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997; 349:151-154.
8. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease on a biracial community study. Journal of American Medical Association 2002; 287:3230-3237.
9. Slooter AJ, van Duijn CM. Genetic epidemiology of Alzheimer disease. Epidemiologic Review 1997; 19: 107-119.
10. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. Journal of American Medical Association 1996; 275:528-532.
11. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. The New England Journal of Medicine 2002; 346(7):476-483.
12. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Annals of Neurology 2002; 52:168-174.
13. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. British Medical Journal 2001; 322:1447-1451.
14. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ. Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiology of Aging 2000; 21:49-55.
15. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002; 51:1256-1262.
16. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. American Journal of Epidemiology 1997; 145(4):301-308.
17. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM. Dietary intake of antioxidants and risk of Alzheimer disease. Journal of American Medical Association 2002; 287:3223-3229.
18. In 't Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MMB, Stricker BHC. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. The New England Journal of Medicine 2001; 345:1515-1521.
19. Launer LJ. Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: Dissecting the epidemiologic evidence. Drugs 2003; 63:731-739.
20. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Archives of Neurology 2002; 59:378-384.
21. Ganguli M, Rodriguez EG. Reporting of dementia on death certificates: a community study. Journal of American Geriatric Society 1999; 47:842-849.
22. Ross GW, Abbott RD, Petrovitch H, Masaki KH, Murdaugh C, Trockman C, Curb JD, White LR. Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia aging study. Journal of American Medical Association 1997; 277:800-805.
23. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12:189-198.
24. Beckett LA. Community-based studies of Alzheimer's disease: statistical challenges in design and analysis. Statistics in Medicine 2000; 19:1469-1480.
25. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999; 53:1292-1299.
26. Izmirlian G, Brock D, White L. Estimating incidence of dementia subtypes: assessing the impact of missed cases. Statistics in Medicine 2000; 19:1577-1591.
27. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. American Journal of Epidemiology 2002; 156:445-453.
28. Touloumi G, Babiker AG, Pocock SJ, Darbyshire JH. Impact of missing data due to drop-outs on estimators of rates of change in longitudinal studies: a simulation study. Statistics in Medicine 2001; 20:3715-3728.
29. Fay, RE, III, Herriot RA. Estimates of income for small places: an application of James-Stein procedures to Census data. Journal of the American Statistical Association 1979; 74:269-277.
30. Tyas SL, White LR, Petrovitch H, Ross GW, Foley DJ, Heimovitz HK, Launer LJ. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiology of Aging 2003; 24:589-596.
31. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145.
32. Farmer ME, White LR, Abbott RD, Kittner SJ, Kaplan E, Wolz MM, Brody JA, Wolf PA. Blood pressure and cognitive performance. The Framingham study. American Journal of Epidemiology 1987; 126:1103-1114.
33. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik R. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia aging study. Journal of American Medical Association 1995; 274:1846-1851.
34. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. International Journal of Epidemiology 1991; 20(Suppl 2):S48-S57.
35. Toga AW, Thompson PM. New approaches in brain morphometry. American Journal of Geriatrics Psychiatry 2002; 10: 13-23.